Alkermes: A More Than Solid Quarter

Group 1 - The article highlights Alkermes plc (NASDAQ: ALKS) as a focus for investment discussions, particularly in the context of covered call opportunities in the biotech sector [1] - Alkermes recently reported its quarterly results, marking the first analysis of the company since the previous article published nearly a year ago [1] - The Biotech Forum, led by Bret, offers a model portfolio featuring 12-20 high upside biotech stocks, along with live discussions and weekly updates on market commentary and portfolio performance [1] Group 2 - The article does not provide any specific financial metrics or performance data for Alkermes plc [3]